Award
NIH Reporter #5U01AG084528-03
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
Recipient
Institute for Molecular Medicine
Award Amount
$1,759,263.00
Ceiling
$1,759,263.00
Awarded
August 10, 2026
Identifier
5U01AG084528-03
Award for IND enabling studies and Phase 1 clinical trial of PV-1950R vaccine for Lewy Body Dementia by the National Institute on Aging.
Description
The project involves manufacturing, safety/toxicology studies, IND submission, and Phase 1 clinical trial for a vaccine targeting Lewy Body Dementia. The project is funded by the NIH/NIA with a budget starting June 1, 2026, and ending May 31, 2027. The project duration is from June 5, 2024, to May 31, 2029. The primary organization is the Institute for Molecular Medicine in Huntington Beach, CA.